|
Status |
Public on May 23, 2017 |
Title |
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Characterization of gene expression changes upon development of taxane-platin drug resistance in NSCLC cells and further, upon treatment of these resistant cells with the Jumonji KDM inhibitor, GSK-J4.
|
|
|
Overall design |
Comparison of gene expression changes between H1299 Parental cells (chemo-sensitive) and H1299 T18 cells (taxane-platin resistant), and comparison of H1299 T18: GSK-J4 treated vs. H1299 T18: DMSO control.
|
|
|
Contributor(s) |
Dalvi MP, Yenerall P, Kollipara RK, Kittler R, Martinez ED, Minna JD |
Citation(s) |
28538184 |
|
Submission date |
May 20, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Ralf Kittler |
E-mail(s) |
Ralf.Kittler@UTSouthwestern.edu
|
Organization name |
University of Texas Southwestern Medical Center
|
Street address |
5323 Harry Hines Blvd
|
City |
Dallas |
State/province |
Texas |
ZIP/Postal code |
75390 |
Country |
USA |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (8)
|
|
This SubSeries is part of SuperSeries: |
GSE81689 |
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors |
|
Relations |
BioProject |
PRJNA322315 |
SRA |
SRP075478 |